U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 2C5H9O2.Zn
Molecular Weight 267.657
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ZINC VALERATE

SMILES

[Zn++].CCCCC([O-])=O.CCCCC([O-])=O

InChI

InChIKey=BUDAIZWUWHWZPQ-UHFFFAOYSA-L
InChI=1S/2C5H10O2.Zn/c2*1-2-3-4-5(6)7;/h2*2-4H2,1H3,(H,6,7);/q;;+2/p-2

HIDE SMILES / InChI

Molecular Formula C5H9O2
Molecular Weight 101.1238
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Zn
Molecular Weight 65.409
Charge 2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Valeric acid is a colorless, oily liquid with an unpleasant odor. It is highly corrosive and must be handled with care. Valeric acid is mainly used as a chemical intermediate to manufacture flavors and perfumes, synthetic lubricants, agricultural chemicals, and pharmaceuticals. It is also used as a flavoring aid in foods. Valeric acid is considered safe as a food additive by the World Health Organization.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
[Comparative studies in man on the percutaneous absorption of diflucortolone valerate, betamethasone-17-valerate, beclomethasone dipropionate and fluocinolone acetonide].
1976
Microflora-associated characteristics in faeces from allergic and nonallergic infants.
2000 Nov
Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) microspheres for the sustained release of 5-fluorouracil.
2001
Evidence for an essential arginine in the flavoprotein nitroalkane oxidase.
2001
Selective functionalization of amino acids in water: a synthetic method via catalytic C-H bond activation.
2001 Aug 22
Effect of estradiol valerate alone or in association with cyproterone acetate upon vascular function of postmenopausal women at increased risk for cardiovascular disease.
2001 Dec 14
Effect of the liquid upflow velocity on thermophilic sulphate reduction in acidifying granular sludge reactors.
2001 Feb
Effect of ruminal vs postruminal administration of degradable protein on utilization of low-quality forage by beef steers.
2001 Jan
Aroma-active components of nonfat dry milk.
2001 Jun
Dehalogenation of dichloroethene in a contaminated soil: fatty acids and alcohols as electron donors and an apparent requirement for tetrachloroethene.
2001 Mar
A two-choice discrimination method to assess olfactory performance in pigtailed macaques, Macaca nemestrina.
2001 Mar
Cometabolic biosynthesis of copolyesters consisting of 3-hydroxyvalerate and medium-chain-length 3-hydroxyalkanoates by Pseudomonas sp. DSY-82.
2001 Oct
beta-Oxidation of simvastatin in mouse liver preparations.
2001 Oct
Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on cardiovascular risk factors.
2001 Sep-Oct
Effect of casein infusion in the rumen, duodenum or both sites on factors affecting forage intake and performance of dairy cows fed red clover-grass silage.
2002 Apr
Comparative study of differentiation levels and valepotriate content of in vitro cultures and regenerated and wild plants of Valeriana edulis ssp.procera.
2002 Apr
Fermentation of cottonseed and other feedstuffs in cattle rumen fluid.
2002 Apr 10
Sensitization of trigeminal caudalis neuronal responses to intraoral acid and salt stimuli and desensitization by nicotine.
2002 Aug
Controlling deuterium isotope effects in comparative proteomics.
2002 Aug 1
A novel synthesis of (+)-biotin from L-cysteine.
2002 Aug 9
Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial.
2002 Dec 21-28
Severe hypertriglyceridemia and pancreatitis following hormone replacement prior to cryothaw transfer.
2002 Feb
Mesophilic acidification of gelatinaceous wastewater.
2002 Feb 14
Thermal degradation of poly(3-hydroxyalkanoates): preparation of well-defined oligomers.
2002 Jan-Feb
Metabolic characteristics of the faecal microflora in humans from three age groups.
2002 Jul
Cyproterone acetate could counteract the benefits of estradiol valerate in oophorectomized cholesterol-fed rabbits.
2002 Jul-Aug
In vitro alterations in fecal short chain fatty acids and organic anions induced by the destruction of intestinal microflora under hypotonic and aerobic conditions.
2002 Jun
Comparison of cryopreservation outcome with gonadotropin-releasing hormone agonists or antagonists in the collecting cycle.
2002 Mar
Structural characterization of in vivo rat glutathione adducts and a hydroxylated metabolite of simvastatin hydroxy acid.
2002 Mar
Modeling of growth, lactate consumption, and volatile fatty acid production by Megasphaera elsdenii cultivated in minimal and complex media.
2002 Mar-Apr
NutriDense and waxy corn hybrids: effects on site and extent of disappearance of nutrients in sheep.
2002 May
Enhancement of NGF- and cholera toxin-induced neurite outgrowth by butyrate in PC12 cells.
2002 Oct 4
Production of purified polyhydroxyalkanoates (PHAs) for applications in contact with blood.
2003
Hydrogen production from wastewater by acidogenic granular sludge.
2003
Parameter identification of thermophilic anaerobic degradation of valerate.
2003 Apr-Jun
Synthesis and cytotoxicity of new platinum(IV) complexes of mixed carboxylates.
2003 Aug 1
Eubacterium pyruvativorans sp. nov., a novel non-saccharolytic anaerobe from the rumen that ferments pyruvate and amino acids, forms caproate and utilizes acetate and propionate.
2003 Jul
Dynamics of the anaerobic process: effects of volatile fatty acids.
2003 Jun 30
[Anti-arrhythmia activity of estradiol valerate and estradiol nitrate].
2003 May-Jun
Heterogeneous acylation of flax fibers. Reaction kinetics and surface properties.
2003 May-Jun
Pelleted beet pulp substituted for high-moisture corn: 3. Effects on ruminal fermentation, pH, and microbial protein efficiency in lactating dairy cows.
2003 Nov
Regulation of glucose-6-phosphatase gene expression in cultured hepatocytes and H4IIE cells by short-chain fatty acids: role of hepatic nuclear factor-4alpha.
2003 Oct 17
Kinetics of thermophilic, anaerobic oxidation of straight and branched chain butyrate and valerate.
2003 Oct 20
The degradability of biodegradable plastics in aerobic and anaerobic waste landfill model reactors.
2004 Jan
Sequential feeding of glucose and valerate in a fed-batch culture of Ralstonia eutropha for production of poly(hydroxybutyrate-co-hydroxyvalerate) with high 3-hydroxyvalerate fraction.
2004 Jan-Feb
Regulation of microglial inflammatory response by sodium butyrate and short-chain fatty acids.
2004 Mar
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
1.5 mM valeric acid is an effective chemical reagent to increase mAb production in rCHO cells.
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:02:33 GMT 2023
Edited
by admin
on Fri Dec 15 16:02:33 GMT 2023
Record UNII
HHJ036TQR0
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ZINC VALERATE
MI   WHO-DD  
Systematic Name English
PENTANOIC ACID ZINC SALT
Common Name English
ZINC VALERIANATE
Common Name English
ZINC VALERATE [MI]
Common Name English
Zinc Valerate [WHO-DD]
Common Name English
Code System Code Type Description
ECHA (EC/EINECS)
209-124-1
Created by admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
PRIMARY
PUBCHEM
68393
Created by admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
PRIMARY
RXCUI
1546360
Created by admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
PRIMARY RxNorm
EPA CompTox
DTXSID00890509
Created by admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
PRIMARY
MERCK INDEX
m11634
Created by admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
PRIMARY Merck Index
DAILYMED
HHJ036TQR0
Created by admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
PRIMARY
CAS
556-38-7
Created by admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
PRIMARY
SMS_ID
100000145791
Created by admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
PRIMARY
FDA UNII
HHJ036TQR0
Created by admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
PRIMARY
EVMPD
SUB124575
Created by admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY